IVF INVO Fertility, Inc.
USHealthcareAs of 2026-08-24
Why IVF matters now
INVO Fertility, Inc. (IVF) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.06 with +0.00% on the session and $1.9M in market capitalization; recent performance reads 1-month +4.90% and YTD -60.11%.
The latest financial table shown here is Q4 2025, with revenue of $1.6M, net income of $475.5K, and EPS of $2.96. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -338.0%.
The latest indexable market news headline is "INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $20.00; recent insider activity includes Krigsvold Terah Renee filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.10
P/S
0.31
EV/EBITDA
-1.35
DCF Value
$-309.22
FCF Yield
-338.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.1%
Operating Margin
-103.8%
Net Margin
-340.9%
ROE
-490.0%
ROA
-115.3%
ROIC
-62.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.6M | $475.5K | $2.96 |
| FY 2025 | $6.8M | $-23.3M | $-66.11 |
| Q3 2025 | $1.8M | $-2.6M | $-1.87 |
| Q2 2025 | $1.9M | $-3.8M | $-22.88 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$20.00
Target (Median)
$20.00
Target Range
$20.00 - $20.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
2.33
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.